about
Biofilm induced tolerance towards antimicrobial peptidesAlternative pre-approved and novel therapies for the treatment of anthraxAn overview of the synthetic routes to the best selling drugs containing 6-membered heterocyclesMolecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014)Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistanceChallenges of antibacterial discoveryCombinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment.Antifungal activity of eupolauridine and its action on DNA topoisomerasesRole of the water-metal ion bridge in mediating interactions between quinolones and Escherichia coli topoisomerase IV.Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridgePrulifloxacin: clinical studies of a broad-spectrum quinolone agent.Rapid and sensitive determination of levofloxacin in microsamples of human plasma by high-performance liquid chromatography and its application in a pharmacokinetic study.Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacinActivity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions.Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.Prediction of mechanisms of action of antibacterial compounds by gene expression profiling.Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance.Ocular toxicity of fluoroquinolones.Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.Mechanism of quinolone action and resistance.Inhaled antibiotics for gram-negative respiratory infections.Medicinal potential of ciprofloxacin and its derivatives.Review of Properties and Analytical Methods for the Determination of Norfloxacin.Preparation of Thermosensitive Gel for Controlled Release of Levofloxacin and Their Application in the Treatment of Multidrug-Resistant Bacteria.Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.Selection and genetic characterization of Streptococcus pneumoniae mutants resistant to the des-F(6) quinolone BMS-284756.Effect of emergence of fluoroquinolone resistance on intrinsic expression of P-glycoprotein phenotype in corneal epithelial cells.The quinolone derivative CHM-1 inhibits murine WEHI-3 leukemia in BALB/c mice in vivo.Design and synthesis of theranostic antibiotic nanodrugs that display enhanced antibacterial activity and luminescence.Quinolone resistance-associated amino acid substitutions affect enzymatic activity of Mycobacterium leprae DNA gyrase.Prevalence of Quinolone Resistance in Enterobacteriaceae from Sierra Leone and the Detection of qnrB Pseudogenes and Modified LexA Binding Sites.Novel Glycoconjugate of 8-Fluoro Norfloxacin Derivatives as Gentamicin-resistant Staphylococcus aureus Inhibitors: Synthesis and Molecular Modelling Studies.Dual effectiveness of Alternaria but not Fusarium mycotoxins against human topoisomerase II and bacterial gyrase.Pharmacokinetic-pharmacodynamic integration of enrofloxacin and its metabolite ciprofloxacin in buffalo calves.Preferential binding of quinolones to DNA with alternating G, C / A, T sequences: a spectroscopic study.Competition of bacteriophage polypeptides with native replicase proteins for binding to the DNA sliding clamp reveals a novel mechanism for DNA replication arrest in Staphylococcus aureus.Effects of ciprofloxacin on salt marsh sediment microbial communities.Early pathophysiologic feature of arthropathy in juvenile dogs induced by ofloxacin, a quinolone antimicrobial agent.Permeability classification of representative fluoroquinolones by a cell culture method.
P2860
Q27301462-E0AC4AC5-E2AE-4ABF-8310-7AAD7DC908C3Q28075453-0CF3ACD6-70DE-4032-BDF0-A102C3E44661Q28301501-536AEB5F-D765-40FA-BC8D-610AF2F18F57Q28552446-C926FAAA-0745-4AD6-AC86-08AE5EF7625FQ33614494-1A2A1CFA-006B-4363-87AB-88244B07B7D0Q33793074-521F66C8-2CC5-4E37-AE4E-572BF8F869F5Q33990519-6E5AFAF1-D7D2-4F44-9DC9-CE1659B72059Q34108803-D9C9438F-A81A-4441-8500-BDCB788A7EDFQ34119765-21F6DADE-BE41-4147-B662-D7651DF47F78Q34597404-34D33EEF-5925-4110-8FDF-45DDA50138A0Q34941542-C61C3BC5-F6AB-4487-BF00-848728A51AA6Q35193051-C31C32B9-638C-4C2E-993B-19C459E5E69AQ35374935-C595DE84-ABFC-471B-92DF-4DB1EBEAD570Q35592636-59077BE9-EB5E-4CB2-B656-7BE7D104998AQ35682250-E2626C80-94B7-4FA8-BDE1-02F26F15441AQ36607348-5DA6B8C8-F226-4EB1-B713-6ED620659BA5Q36670294-2A02CAD0-84D7-4297-AC58-A936655C9305Q36783606-E89988CE-2780-48F1-8A89-351961865DB7Q36924311-E59BE7E4-AF95-4E70-B873-BE08A31172EEQ37407949-D33850C4-2DB7-460E-B2B9-65AD02D8F0E7Q37701591-76B4DE4D-C673-41A8-824A-E1992C5247E1Q37937558-5362FAD6-BCFB-4716-B287-A6747807DD1EQ38068970-65148B3E-A6B3-4360-A5DE-8C38863ECA4BQ38591662-BFE09719-C027-43A8-A67B-002C60FC2EB5Q38816087-D13CB8B3-79A9-465D-8ED0-045FDCF5A223Q39476879-EC0E4CC5-C210-4F1B-A464-40D3E3F139E0Q39478563-CEF8AC85-6729-4914-86D5-F39B8D936A4AQ39492357-387EFB77-10EE-4762-88AD-896A60631B9FQ39655230-1509DD96-7258-445C-A1D6-E1BF731659F4Q40119937-C4C1B9AC-5C46-4ED7-AE64-AABDE462C10CQ40247693-1CB93B9A-BF90-4541-9E20-A472782A6181Q40559404-A6FAC153-9659-4A03-83FA-87549B6DF36EQ41578032-DE18D1B6-B796-4D79-8177-953D5EC63CFCQ42314511-E40E0465-88BB-45AF-9E08-251BE8602E42Q42682745-A0A2E2D1-8CB7-4260-97DF-F7A8E92B2127Q44158345-7BE50972-CFB3-471C-8921-E045143C0145Q44543395-7A6CB766-3122-4DCC-B81F-627B78B8E3E6Q44566002-491F28AA-C044-47D5-BCE0-DD7E9DBC9FA0Q45158524-A32677CE-6267-43B7-9B5E-ECC237EC7575Q46369508-F174F8A8-0246-43DA-8891-7A796197B5B7
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mode of action of fluoroquinolones.
@ast
Mode of action of fluoroquinolones.
@en
type
label
Mode of action of fluoroquinolones.
@ast
Mode of action of fluoroquinolones.
@en
prefLabel
Mode of action of fluoroquinolones.
@ast
Mode of action of fluoroquinolones.
@en
P1433
P1476
Mode of action of fluoroquinolones.
@en
P2093
P356
10.2165/00003495-199958002-00002
P478
58 Suppl 2
P577
1999-01-01T00:00:00Z
P6179
1021708805